← Eichor
Study identifier: NCT06279676 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Improvement of Women's Health After Allogeneic Stem Cell Transplantation

Condition: GVHD, Chronic  ·  Sponsor: Ciusss de L'Est de l'Île de Montréal

PhaseN/A
Planned participants100
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this prospective research project is to better understand vulvovaginal cGVHD to improve care of allografted women. The expected outcomes include better knowledge of the incidence and manifestations of vulvovaginal cGVHD, risk factors, response to treatments and impact on sexual health of allotransplanted female patients. The knowledge acquired will allow transplant clinicians to make more precise recommendations for gynecological management of future allografted women.

This description comes directly from the study's public registry record.

Talk to the study team

Michel-Olivier Gratton  ·  514-252-3400  ·  mogratton.hmr@ssss.gouv.qc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

CIUSSS de l'Est-de-l'Ile-de-Montréal / Hôpital Maisonneuve-RosemontMontreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06279676